Baltimore biotech backed by more than $300M in funding names new CEO

The company hopes to provide a cheaper alternative to the standard screening for lung cancer.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 5, 2024 Category: Pharmaceuticals Authors: Matt Hooke Source Type: news